28.7 C
New York
Friday, June 12, 2026

Tag: cash equivalents

Minesto publishes Half-Year Report 2025

GOTHENBURG, Sweden, Aug. 14, 2025 /PRNewswire/ -- CEO Dr Martin Edlund: "As the leading pioneer in Ocean Renewable Energy, Minesto moves on with more determination and...

Minesto publishes Half-Year Report 2025

GOTHENBURG, Sweden, Aug. 14, 2025 /PRNewswire/ -- CEO Dr Martin Edlund: "As the leading pioneer in Ocean Renewable Energy, Minesto moves on with more determination and...

Consolidated Interim Report 1 January – 30 June 2025

Consolidated Interim Report 1 January – 30 June 2025
Key points from the H1-2025 report (period 1 January - 30 June 2025)

Zeekr Group Reports Second Quarter 2025 Unaudited Financial Results

HANGZHOU, China, Aug. 14, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new...

FRONTERA ANNOUNCES SECOND QUARTER 2025 RESULTS

Recorded $455.2 million in Net Loss Mainly due to Non-Cash Impairment Charges Related to its Interest in the Corentyne License and Ecuadorian Assets Increased Total...

FRONTERA ANNOUNCES SECOND QUARTER 2025 RESULTS

Recorded $455.2 million in Net Loss Mainly due to Non-Cash Impairment Charges Related to its Interest in the Corentyne License and Ecuadorian Assets Increased Total...

Entrepreneur Universe Bright Group Reports Second Quarter 2025 Financial Results

XI'AN, China, Aug. 14, 2025 /PRNewswire/ -- Entrepreneur Universe Bright Group ("EUBG" or the "Company"), a Nevada corporation, today announced its unaudited financial results for...

DRI Healthcare Reports Second Quarter 2025 Results

Subsequent to the end of the quarter, completed the previously announced transaction to internalize its investment management functionPortfolio assets generate Total Income of $44.1...

Optiva Inc. Reports Second Quarter 2025 Financial Results

All amounts are stated in United States dollars unless otherwise indicated

Binah Capital Group Reports Second Quarter 2025 Results

- Grew Total Revenue 2% Year-over-Year to $42 Million -

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update.

Applied Therapeutics Reports Second Quarter 2025 Financial Results

- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD

Stardust Power Announces Q2 2025 Financial Results

Stardust Power Q2 2025 earnings release

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCash equivalents